Results of a phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non–small-cell lung cancer

SE Schild, WL McGinnis, D Graham, S Hillman… - International Journal of …, 2006 - Elsevier
Purpose: This trial was performed to determine the maximum tolerated dose (MTD) of
radiation that can be administered with carboplatin and paclitaxel. Methods and Materials …
被引用次数：132 相关文章

Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer.

SE Schild, WL McGinnis, D Graham… - … Journal of Radiation …, 2006 - europepmc.org
Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for
unresectable non-small-cell lung cancer. - Abstract - Europe PMC Sign in | Create an account …

Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer

SE Schild, WL McGinnis, D Graham… - … journal of radiation …, 2006 - pubmed.ncbi.nlm.nih.gov
Purpose This trial was performed to determine the maximum tolerated dose (MTD) of
radiation that can be administered with carboplatin and paclitaxel. Methods and materials …

[引用][C] Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non–small-cell lung cancer

SE Schild, WL McGinnis, D Graham, S Hillman… - International Journal of …, 2006 - cir.nii.ac.jp
Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for
unresectable non–small-cell lung cancer | CiNii Research CiNii 国立情報学研究所 学術情報 …

Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer

SE Schild, WL McGinnis, D Graham, S Hillman… - International Journal of …, 2006 - osti.gov
Purpose: This trial was performed to determine the maximum tolerated dose (MTD) of
radiation that can be administered with carboplatin and paclitaxel. Methods and Materials …

Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer

SE Schild, WL McGinnis, D Graham… - International Journal of …, 2006 - inis.iaea.org
[en] Purpose: This trial was performed to determine the maximum tolerated dose (MTD) of
radiation that can be administered with carboplatin and paclitaxel. Methods and Materials …

Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non–small-cell lung cancer

SE Schild, WL McGinnis, D Graham… - International Journal of …, 2006 - redjournal.org
Purpose: This trial was performed to determine the maximum tolerated dose (MTD) of
radiation that can be administered with carboplatin and paclitaxel. Methods and Materials …

Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non–small-cell lung cancer

SE Schild, WL McGinnis, D Graham, S Hillman… - International Journal of …, 2006 - infona.pl
Purpose: This trial was performed to determine the maximum tolerated dose (MTD) of
radiation that can be administered with carboplatin and paclitaxel. Methods and Materials …

Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer

SE Schild, WL McGinnis… - International …, 2006 - mayoclinic.elsevierpure.com
Purpose: This trial was performed to determine the maximum tolerated dose (MTD) of
radiation that can be administered with carboplatin and paclitaxel. Methods and Materials …

[引用][C] Results of a phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer

S SE - Int J Radiat Oncol Biol Phys, 2006 - cir.nii.ac.jp
Results of a phase I trial of concurrent chemotherapy and escalating doses of radiation for
unresectable non-small-cell lung cancer | CiNii Research CiNii 国立情報学研究所 学術情報 …